Courses

Title	Credit	Type	Cost
Immunopathology: Evaluation from Discovery to Safety Assessment	0.50 Participation	Enduring	$25.00
Regulatory guidance: Introduction		Enduring	$25.00
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities)		Enduring	$25.00
TDAR assessments	0.50 Participation	Enduring	$25.00
Nonclinical Development of Biologics	0.50 Participation	Enduring	$25.00
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities)		Enduring	$25.00
Basic principles of toxicology, toxicology of the immune system, relevance to immunosafety		Enduring	$25.00
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.)		Enduring	$25.00
Immunopathology: evaluation, assessment, and considerations		Enduring	$25.00
Basic Immunology: Introduction to Immune Cells and Innate and Adaptive Immunity	1.00 Participation	Enduring	$25.00
CAR Therapy	0.50 Participation	Enduring	$25.00
Assessing adversity in immunosafety (preclinical)		Enduring	$25.00
Cytokine Release Syndrome (CRS)	0.50 Participation	Enduring	$25.00
CD3-binding (T cell engaging) immune stimulating antibody-based therapies	0.50 Participation	Enduring	$25.00
Immune-related adverse events (clinical)		Enduring	$25.00

HESI E-Learning